Xoft
Status
Conditions
Treatments
About
This is a retrospective-prospective study design. Patients who completed treatment approximately 3 years (range of 2-4 years) at time of IRB approval of this study will be identified and any existing data in the patient's record will be collected in addition to conducting office visits for long-term follow-up.
Full description
This is a retrospective-prospective study design. Patients who completed treatment approximately 3 years (range of 2-4 years) at time of IRB approval of this study will be identified and any existing data in the patient's record will be collected in addition to conducting office visits for long-term follow-up. The study will include 2 parts:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Previously completed treatment for non-melanoma skin cancer using Xoft eBx Electronic Brachytherapy System or Mohs surgery;
Provides informed Consent;
Greater than 40 years of age;
Pathological diagnosis confirmed to be squamous cell or basal cell carcinoma prior to treatment;
Cancer Staging included in this study:
Exclusion criteria
369 participants in 2 patient groups
Loading...
Central trial contact
John DeLucia; Joyce Musacchio
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal